323 related articles for article (PubMed ID: 26071816)
1. Characteristics of post-menopausal women with genitourinary syndrome of menopause: Implications for vulvovaginal atrophy diagnosis and treatment selection.
Castelo-Branco C; Biglia N; Nappi RE; Schwenkhagen A; Palacios S
Maturitas; 2015 Aug; 81(4):462-9. PubMed ID: 26071816
[TBL] [Abstract][Full Text] [Related]
2. Post-menopausal vulvovaginal atrophy - an overview of the current treatment options.
Szymański JK; Siekierski BP; Kajdy A; Jakiel G
Ginekol Pol; 2018; 89(1):40-47. PubMed ID: 29411346
[TBL] [Abstract][Full Text] [Related]
3. The Association Between Vulvovaginal Atrophy Symptoms and Quality of Life Among Postmenopausal Women in the United States and Western Europe.
DiBonaventura M; Luo X; Moffatt M; Bushmakin AG; Kumar M; Bobula J
J Womens Health (Larchmt); 2015 Sep; 24(9):713-22. PubMed ID: 26199981
[TBL] [Abstract][Full Text] [Related]
4. The REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: Country-specific comparisons of postmenopausal women's perceptions, experiences and needs.
Nappi RE; Palacios S; Particco M; Panay N
Maturitas; 2016 Sep; 91():81-90. PubMed ID: 27451325
[TBL] [Abstract][Full Text] [Related]
5. Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey.
Nappi RE; Particco M; Biglia N; Cagnacci A; Di Carlo C; Luisi S; Paoletti AM
Maturitas; 2016 Sep; 91():74-80. PubMed ID: 27451324
[TBL] [Abstract][Full Text] [Related]
6. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.
Nappi RE; Palacios S; Panay N; Particco M; Krychman ML
Climacteric; 2016 Apr; 19(2):188-97. PubMed ID: 26581580
[TBL] [Abstract][Full Text] [Related]
7. The effect of vulvovaginal atrophy on women's quality of life from an Italian cohort of the EVES study.
Nappi RE; Di Carlo C; Becorpi AM; Gambacciani M; De Seta F; Ribaldone R; Benedetto C; Paoletti AM;
J Obstet Gynaecol; 2020 May; 40(4):512-519. PubMed ID: 31496326
[TBL] [Abstract][Full Text] [Related]
8. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
Vicariotto F; Raichi M
Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
[TBL] [Abstract][Full Text] [Related]
9. Viewing symptoms associated with Vulvovaginal Atrophy (VVA)/Genitourinary syndrome of menopause (GSM) through the estro-androgenic lens - Cluster analysis of a web-based Italian survey among women over 40.
Nappi RE; Di Carlo C; Cucinella L; Gambacciani M
Maturitas; 2020 Oct; 140():72-79. PubMed ID: 32616374
[TBL] [Abstract][Full Text] [Related]
10. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
Vicariotto F; DE Seta F; Faoro V; Raichi M
Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
[TBL] [Abstract][Full Text] [Related]
11. Impact of vulvovaginal atrophy of menopause: prevalence and symptoms in Italian women according to the EVES study.
Nappi RE; Seracchioli R; Salvatore S; Cagnacci A; Di Paolantonio T; Busacca M;
Gynecol Endocrinol; 2019 May; 35(5):453-459. PubMed ID: 30700188
[TBL] [Abstract][Full Text] [Related]
12. Vulvovaginal atrophy of menopause and its impact on sexual function in an Italian clinical cohort of post-menopausal women.
Nappi RE; Guida M; Marchesoni D; Cianci A; Pellegrino A; Remorgida V; Di Paolantonio T; Benedetti Panici P;
J Obstet Gynaecol; 2021 Feb; 41(2):290-297. PubMed ID: 33432869
[TBL] [Abstract][Full Text] [Related]
13. Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data.
Nappi RE; Particco M; Biglia N; Cagnacci A; Di Carlo C; Luisi S; Paoletti AM
Gynecol Endocrinol; 2017 May; 33(5):389-394. PubMed ID: 28277131
[TBL] [Abstract][Full Text] [Related]
14. The burden of vulvovaginal atrophy on women's daily living: implications on quality of life from a face-to-face real-life survey.
Nappi RE; Palacios S; Bruyniks N; Particco M; Panay N;
Menopause; 2019 May; 26(5):485-491. PubMed ID: 30422932
[TBL] [Abstract][Full Text] [Related]
15. Vulvar and vaginal atrophy as viewed by the Spanish REVIVE participants: symptoms, management and treatment perceptions.
Palacios S; Cancelo MJ; Castelo Branco C; Llaneza P; Molero F; Borrego RS
Climacteric; 2017 Feb; 20(1):55-61. PubMed ID: 28042734
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy.
Pérez-López FR; Vieira-Baptista P; Phillips N; Cohen-Sacher B; Fialho SCAV; Stockdale CK
Gynecol Endocrinol; 2021 Aug; 37(8):740-745. PubMed ID: 34036849
[TBL] [Abstract][Full Text] [Related]
17. Iranian postmenopausal women's experiences of treatment of symptomatic vulvovaginal atrophy.
Fooladi E; Deldar M; Mohammadzadeh F; Ahmadnia E; Khani S; Ghanbari Z
Climacteric; 2017 Feb; 20(1):67-71. PubMed ID: 28064523
[TBL] [Abstract][Full Text] [Related]
18. The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate.
Krychman M; Graham S; Bernick B; Mirkin S; Kingsberg SA
J Sex Med; 2017 Mar; 14(3):425-433. PubMed ID: 28202319
[TBL] [Abstract][Full Text] [Related]
19. Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause.
Nappi RE; Palacios S
Climacteric; 2014 Feb; 17(1):3-9. PubMed ID: 24423885
[TBL] [Abstract][Full Text] [Related]
20. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.
Kingsberg SA; Wysocki S; Magnus L; Krychman ML
J Sex Med; 2013 Jul; 10(7):1790-9. PubMed ID: 23679050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
